Methods for treatment or prophylaxis of atherosclerosis and...

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 38/16 (2006.01)

Patent

CA 2654440

The invention provides the use of a complement inhibitor in the preparation of a medicament for the treatment or prophylaxis of atherosclerosis in a subject in need of treatment by administering to the subject a therapeutically effective amount of said medicament. The complement inhibitor may be a molecule which can inhibit activation of at least one complement component, inhibit activity of at least one activated complement component, act as an antagonist against at least one complement receptor, or combinations thereof.

L'invention concerne l'utilisation d'un inhibiteur complémentaire dans la préparation d'un médicament pour le traitement ou la prophylaxie de l'athérosclérose chez un patient nécessitant un traitement par administration d'une dose thérapeutiquement efficace dudit médicament. L'inhibiteur complémentaire peut être une molécule susceptible d'inhiber l'activation d'au moins un composant complémentaire, l'activité d'au moins un composant complémentaire activé, d'agir comme un antagoniste contre au moins un récepteur complémentaire, ou une combinaison de ceux-ci.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Methods for treatment or prophylaxis of atherosclerosis and... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Methods for treatment or prophylaxis of atherosclerosis and..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods for treatment or prophylaxis of atherosclerosis and... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1472335

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.